The World of Health & Medicine News

Help with heart health, blood sugar control, and weight management by eating breakfast earlier

Help with heart health, blood sugar control, and weight management by eating breakfast earlier

Studies show that the human body is more sensitive to the hormone insulin in the morning, which means it can process carbohydrates more efficiently, helping to stabilize blood sugar and energy levels throughout the day.

From a metabolic perspective, eating breakfast before 8:30 a.m. is ideal and helps regulate appetite and reduce calorie intake, which leads to greater weight loss, improved triglyceride levels, glucose regulation, and reduced hunger levels, because hunger hormones follow a specific cycle and pattern based on when we typically eat.

This also aligns with another study that found that eating breakfast after 9 a.m. was associated with a higher risk of heart disease, so eating breakfast earlier may also be beneficial for heart health.

And finally:
The timing of eating is only one piece of the puzzle. The quality of meals with more protein and fiber and the amount of calories we consume are as important as the right time we eat and can help us feel full sooner, promote muscle growth and repair, and generally reduce cravings and overeating.

spot_img

Explore more

spot_img

New lasso-shaped antibiotic kills drug-resistant bacteria

New lasso-shaped antibiotic kills drug-resistant bacteria Researchers at McMaster University have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including...

Chinese brain chip project speeds up human trials after first success

Chinese brain chip project speeds up human trials after first success A tie-up between a Chinese research institute and tech company said on Monday that...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by 94 percent According to results published in the New England Journal of Medicine: In a...

Novo Nordisk to license obesity drug from Lexicon in up to...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O),...

Vykat XR approved for genetic binge eating disorder

For the first time/ Vykat XR approved for genetic binge eating disorder The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics’ drug to...

Keytruda subcutaneous injection to launch on October 1

Keytruda subcutaneous injection to launch on October 1 Merck & Co. said Thursday it plans to launch a subcutaneous injection of its best-selling cancer immunotherapy,...

Buying an autoimmune disease drug for $1.3 billion

Sanofi/ Buying an autoimmune disease drug for $1.3 billion Sanofi announced Thursday that it has agreed to buy the biopharmaceutical company’s autoimmune disease drug Dren Bio...

US FDA approves Sanofi’s bleeding disorder therapy

US FDA approves Sanofi's bleeding disorder therapy The U.S. Food and Drug Administration approved French drugmaker Sanofi's (SASY.PA), opens new tab hemophilia therapy, introducing a new...